1. Lekanne Deprez RH, Groen NA, van Biezen NA, Hagemeijer A, van Drunen E, Koper JW et al. A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. Am J Hum Genet 1991; 48: 783–790.
2. Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma 8. Oncogene 1995; 10: 1521–1528.
3. Buijs A, van Rompaey L, Molijn AC, Davis JN, Vertegaal AC, Potter MD et al. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity 24. Mol Cell Biol 2000; 20: 9281–9293.
4. van Wely KH, Molijn AC, Buijs A, Meester-Smoor MA, Aarnoudse AJ, Hellemons A et al. The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription 5. Oncogene 2003; 22: 699–709.
5. Chen Z, Fisher RJ, Riggs CW, Rhim JS, Lautenberger JA . Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides 10. Cancer Res 1997; 57: 2013–2019.